Small molecule · Antagonist of beta-adrenergic receptor · developed by Wyeth Pharms
ApprovedFDA, Nov 1967
1Registered trials
What is Propranolol?
Propranolol is a nonselective beta-adrenergic receptor blocker that competitively antagonizes beta-adrenergic receptors, reducing cardiac output and inhibiting renin release. It is used to treat hypertension and is studied in migraine.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Aug 27, 2026). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.